Thermo Fisher Scientific Inc (TMO)

Industry Diagnostics & Research


This stock can be held in an Investment ISA and an Investment Account
Sell

$467.88

Buy

$469.88

arrow-up$3.01 (+0.65%)

Prices updated at 25 Apr 2026, 00:27 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Thermo Fisher Scientific Inc is a healthcare company. It offers analytical instruments, laboratory equipment, software, services, consumables, reagents and chemicals.

Income statement

20242025
42,879m44,557m
17,702m18,239m
7,717m8,110m
18.0018.20
6,335m6,704m
11,535m11,507m
Sales, General and administrative8,595m8,732m
Interest expenses1,390m1,419m
Provision for income taxes657m547m
Operating expenses9,985m10,129m
Income before taxes7,037m7,308m
Net income available to common shareholders6,335m6,704m
16.5817.77
Net interest income-312m-426m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)16.5317.74
Free cash flow per share20.234216.1134
Book value/share128.6641135.6063
Debt equity ratio0.5860850.671298

Balance sheet

20242025
Current assets22,137m28,707m
Current liabilities13,332m15,189m
Total capital78,646m89,259m
Total debt31,275m39,385m
Total equity49,585m53,407m
Total non current liabilities--
Loans29,061m35,852m
Total assets97,321m110,343m
Total liabilities--
Cash and cash equivalents4,009m9,852m
Common stock381m376m

Cash flow

20242025
Cash at beginning of period8,097m4,040m
Cash dividends paid-583m-636m
7,267m6,293m
Investments (gains) losses-5,841m-4,047m
4,040m9,879m
Net income--
8,667m7,818m
-1,400m-1,525m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.